Enanta Pharmaceuticals Stock Performance
as on August 22, 2026 at 2:15 pm IST
Day's Low
Day's High
$13.09$13.69
2.82%
Downside
1.63%
Upside
52 Week's Low
52 Week's High
$7.05$17.1547.66%
Downside
27.32%
Upside
Enanta Pharmaceuticals share price movements today
- Previous Close
- $13.13
- Open
- $13.32
- Volume
- 349.2K
- Market Cap
- $383.3M
- Day's Low - High
- $13.09 - $13.69
- 52 Week Low - High
- $7.05 - $17.15
Enanta Pharmaceuticals Historical Returns
- 1 Month Return
- -4.22 %
- 3 Month Return
- -1.86 %
- 1 Year Return
- + 64.5 %
- 3 Year Return
- -15.96 %
- 5 Year Return
- -72.59 %
Enanta Pharmaceuticals Stock Fundamentals & Key Indicators
Check Enanta Pharmaceuticals market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$383.3M
EPS (TTM)
-2.425
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
-0.66%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-53.8M
Revenue (TTM)
65.3M
Profit Margin
-96.89%
Return On Equity TTM
-70.12%
Enanta Pharmaceuticals vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Enanta Pharmaceuticals with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| BUY | $383.3M | -72.59% | NA | -96.89% | NA | |
| BUY | $43.7B | 669.3% | NA | 0.00% | NA | |
| BUY | $128.2B | 154.86% | 29.82 | 86.04% | NA | |
| BUY | $25.3B | -84.24% | -7.98 | -12.57% | NA | |
| BUY | $82.7B | 24.1% | 19.24 | 84.86% | 0.44999999999999996% |
Stock Returns calculator for Enanta Pharmaceuticals Stock including INR - Dollar returns
The Enanta Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Enanta Pharmaceuticals investment value today
Current value as on today
₹1,84,530
Returns
₹84,530
(+84.53%)
Returns from Enanta Pharmaceuticals Stock
₹68,375 (+68.38%)
Dollar Impact
₹16,155 (+16.15%)
Analyst Recommendation on Enanta Pharmaceuticals Stock
Based on 1 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
Based on 1 analysts, 100% of analysts recommend a 'BUY' rating for Enanta Pharmaceuticals. Average target price of $21.17
Enanta Pharmaceuticals Share Price Target
Get share price movements and forecasts by analysts on Enanta Pharmaceuticals.
What analysts predicted
36.37%UPSIDE
Target Price
$21.17
Current Price
$13.47
Analyzed by
1 Analysts
Target
$21.17
Enanta Pharmaceuticals target price $21.17, a slight upside of 36.37% compared to current price of $13.47. According to 1 analysts rating.
Indian Investors' Interest in Enanta Pharmaceuticals Stock
Search interest for Enanta Pharmaceuticals Stock has decreased by -49% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Enanta Pharmaceuticals Quarterly Profit & Loss
All numbers in Millions USD
Enanta Pharmaceuticals Annual Profit & Loss
All numbers in Millions USD
Enanta Pharmaceuticals Quarterly Cash Flow
All numbers in Millions USD
Enanta Pharmaceuticals Annual Cash Flow
All numbers in Millions USD
Enanta Pharmaceuticals News & Key Events
Today's Timeline - 23 June
Tue, 02:40 PM
-AbbVie receives EU approval for MAVIRET, a significant treatment for acute Hepatitis C, benefiting Enanta's partnership.
Wed, 04:20 AM
-U.S. Court of Appeals invalidates Enanta's patent claims against Pfizer regarding Paxlovid, impacting its IP strategy.
Insights on Enanta Pharmaceuticals
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 1 year, ENTA stock has moved up by 52.5%
NO EFFECTAgainst Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 586.8% return, outperforming this stock by 599.0%
- NO EFFECT
Against Peers
In the last 1 year, Revolution Medicines, Inc. Common Stock has given 466.0% return, outperforming this stock by 413.5%
NEGATIVE IMPACTProfit Down
Netprofit is down for the last 3 quarters, -11.93M → -19.50M (in $), with an average decrease of 29.3% per quarter
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 3 quarters, 18.61M → 14.35M (in $), with an average decrease of 12.1% per quarter
About Enanta Pharmaceuticals
| Organisation | Enanta Pharmaceuticals |
| Headquarters | 4 Kingsbury Avenue, Watertown, MA, United States, 02472 |
| Industry | Biotechnology |
| CEO | Dr. Jay R. Luly Ph.D. |
| E-voting on shares | Click here to vote |
Key Management of Enanta Pharmaceuticals
Name | Title |
|---|---|
Mr. Harry R. Trout III | VP of Finance & Interim Principal Financial Officer |
Ms. Jennifer Viera | Executive Director of Investor Relations & Corporate Communications |
Mr. Matthew P. Kowalsky J.D. | Chief Legal Officer & Corporate Secretary |
Mr. Nathaniel S. Gardiner J.D. | Consultant |
Ms. Tara Lynn Kieffer Ph.D. | Chief Product Strategy Officer |
Mr. Brendan Luu | Chief Business Officer |
Dr. Scott T. Rottinghaus M.D. | Chief Medical Officer |
Dr. Yat Sun Or Ph.D. | Chief Scientific Officer |
Ms. Kathleen S. Capps CPA | Executive Director of Accounting, Controller & Interim Principal Accounting Officer |
Dr. Jay R. Luly Ph.D. | President, CEO & Director |
FAQs
What is Enanta Pharmaceuticals share price today?
Enanta Pharmaceuticals share price today is $13.47 as on at the close of the market. Enanta Pharmaceuticals share today touched a day high of $13.69 and a low of $13.09.
What is the 52 week high and 52 week low for Enanta Pharmaceuticals share?
Enanta Pharmaceuticals share touched a 52 week high of $17.15 on and a 52 week low of $7.05 on . Enanta Pharmaceuticals stock price today i.e. is closed at $13.47,which is 21.46% down from its 52 week high and 91.06% up from its 52 week low.
What is Enanta Pharmaceuticals's market capitalisation today?
Enanta Pharmaceuticals market capitalisation is $0.00T as on .
How to invest in Enanta Pharmaceuticals Stock (ENTA) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Enanta Pharmaceuticals on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Enanta Pharmaceuticals Shares that will get you 0.1114 shares as per Enanta Pharmaceuticals share price of $13.47 per share as on August 22, 2026 at 8:45 am IST.
What is the minimum amount required to buy Enanta Pharmaceuticals Stock (ENTA) from India?
Indian investors can start investing in Enanta Pharmaceuticals (ENTA) shares with as little as ₹95.71 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹957.10 in Enanta Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on ).
Based on Enanta Pharmaceuticals share’s latest price of $13.47 as on August 22, 2026 at 8:45 am IST, you will get 0.7424 shares of Enanta Pharmaceuticals. Learn more about
fractional shares .
What are the returns that Enanta Pharmaceuticals has given to Indian investors in the last 5 years?
Enanta Pharmaceuticals stock has given -72.59% share price returns and 29.17% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?